Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
pT3: Multiple tumours more than 5 cm or tumour involving a major branch of the portal or hepatic vein(s) (liver, including intrahepatic bile ducts) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT4: Tumour(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum (liver, including intrahepatic bile ducts) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Renal tumour limited to kidney macroscopically |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Adrenal gland involved by direct invasion of renal tumour |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Adrenal gland involved by metastasis from renal tumour |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Hyperkeratosis |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
1 |
Extent of stromal invasion by tumour cannot be assessed |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Uterine cervix TNM finding |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT1 (I): Cervical carcinoma confined to uterus (extension to corpus should be disregarded) (TNM category and FIGO stage) (uterine cervix) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT1a (IA): Invasive carcinoma diagnosed only by microscopy. All macroscopically visible lesions (even with superficial invasion) are pT1b/IB (TNM category and FIGO stage) (uterine cervix) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT1a1 (IA1): Measured stromal invasion 3.0 mm or less in depth and 7.0 mm or less in horizontal spread (TNM category and FIGO stage) (uterine cervix) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT1a2 (IA2): Measured stromal invasion more than 3.0 mm and not more than 5.0 mm in depth and 7.0 mm or less horizontal spread (TNM category and FIGO stage) (uterine cervix) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT1b (IB): Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a2/IA2 (TNM category and FIGO stage) (uterine cervix) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT1b1 (IB1): Clinically visible lesion 4.0 cm or less in greatest dimension (TNM category and FIGO stage) (uterine cervix) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT1b2 (IB2): Clinically visible lesion more than 4.0 cm in greatest dimension (TNM category and FIGO stage) (uterine cervix) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT2 (II): Cervical carcinoma invades beyond uterus but not to pelvic wall or to lower third of vagina (TNM category and FIGO stage) (uterine cervix) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT2a (IIA): Tumor without parametrial invasion (TNM category and FIGO stage) (uterine cervix) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT2b (IIB): Tumour with parametrial invasion (TNM category and FIGO stage) (uterine cervix) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT3 (III): Tumour extends to pelvic wall and/or involves lower third of vagina and/or causes hydronephrosis or non-functioning kidney (TNM category and FIGO stage) (uterine cervix) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT3a (IIIA): Tumour involves lower third of vagina, no extension to pelvic wall (TNM category and FIGO stage) (uterine cervix) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT3b (IIIB): Tumour extends to pelvic wall and/or causes hydronephrosis or non-functioning kidney (TNM category and FIGO stage) (uterine cervix) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT4 (IVA): Tumour invades mucosa of bladder or rectum and/or extends beyond true pelvis (bullous oedema is not sufficient evidence to classify a tumour as pT4) (TNM category and FIGO stage) (uterine cervix) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pM1 (IVB): Distant metastasis (TNM category and FIGO stage) (corpus uteri) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Myometrial invasion by tumour absent |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Myometrial invasion by tumour present |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Corpus uteri TNM finding |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT1 (I): Tumour confined to corpus uteri (TNM category and FIGO stage) (corpus uteri) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT1a (IA): Tumour limited to endometrium (TNM category and FIGO stage) (corpus uteri) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT1b (IB): Tumour invades less than one-half of the myometrium (TNM category and FIGO stage) (corpus uteri) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT1c (IC): Tumour invades one-half or more of the myometrium (TNM category and FIGO stage) (corpus uteri) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT2 (II): Tumour invades cervix but does not extend beyond uterus (TNM category and FIGO stage) (corpus uteri) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT2a (IIA): Tumour limited to the glandular epithelium of the endocervix. There is no evidence of connective tissue stromal invasion (TNM category and FIGO stage) (corpus uteri) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT2b (IIB): Invasion of the stromal connective tissue of the cervix (TNM category and FIGO stage) (corpus uteri) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT3 (III): Local and/or regional spread as specified in pT3a, pT3b, pN1, and FIGO IIIA, IIIB, and IIIC (TNM category and FIGO stage) (corpus uteri) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT3a (IIIA): Tumour involves serosa, AND/OR adnexa (direct extension or metastasis) AND/OR cancer cells in ascites or peritoneal washings (TNM category and FIGO stage) (corpus uteri) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT3b (IIIB): Involvement of vagina (direct extension or metastasis), rectal or bladder wall (without mucosal involvement), or pelvic wall(s) (frozen pelvis) (TNM category and FIGO stage) (corpus uteri) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT4 (IVA): Tumour invades bladder mucosa and/or bowel mucosa (TNM category and FIGO stage) (corpus uteri) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pN1 (IIIC): Regional lymph node metastasis (TNM category and FIGO stage) (corpus uteri) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Tumour site not applicable |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Lesion size cannot be determined |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Skin melanoma TNM finding |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pTis: Melanoma in situ (melanoma of the skin) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT1: Melanoma 1.0 mm or less in thickness, with or without ulceration (melanoma of the skin) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT1a: Melanoma 1.0 mm or less in thickness and level II or III, no ulceration (melanoma of the skin) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT1b: Melanoma 1.0 mm or less in thickness and level IV or V or with ulceration (melanoma of the skin) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT2: Melanoma 1.01 to 2.0 mm in thickness, with or without ulceration (melanoma of the skin) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration (melanoma of the skin) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration (melanoma of the skin) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT3: Melanoma 2.01 to 4.0 mm in thickness, with or without ulceration (melanoma of the skin) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT3a: Melanoma 2.01 to 4.0 mm in thickness, no ulceration (melanoma of the skin) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT3b: Melanoma 2.01 to 4.0 mm in thickness, with ulceration (melanoma of the skin) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT4: Melanoma greater than 4.0 mm in thickness, with or without ulceration (melanoma of the skin) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT4a: Melanoma greater than 4.0 mm in thickness, no ulceration (melanoma of the skin) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pT4b: Melanoma greater than 4.0 mm in thickness, with ulceration (melanoma of the skin) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pN1: Metastasis in one regional lymph node (melanoma of the skin) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pN1a: Clinically occult (microscopic) metastasis (melanoma of the skin) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pN1b: Clinically apparent (macroscopic) metastasis (melanoma of the skin) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pN2: Metastasis in 2 to 3 regional nodes or intralymphatic regional metastasis without nodal metastasis (melanoma of the skin) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pN2a: Clinically occult (microscopic) metastasis (melanoma of the skin) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pN2b: Clinically apparent (macroscopic) metastasis (melanoma of the skin) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pN2c: Satellite or in-transit metastasis without nodal metastasis (melanoma of the skin) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pN3: Metastasis in four or more regional nodes, or matted metastatic nodes, or in-transit metastasis or satellite(s) with metastasis in regional node(s) (melanoma of the skin) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pM1a: Metastasis to skin, subcutaneous tissues, or distant lymph nodes (melanoma of the skin) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pM1b: Metastasis to lung (melanoma of the skin) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
pM1c: Metastasis to visceral site other than lung or distant metastasis at any site associated with an elevated serum lactic dehydrogenase (LDH) (melanoma of the skin) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Perineural invasion by tumour indeterminate |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Perineural invasion finding |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Tumour infiltration by lymphocytes absent |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Tumour infiltration by lymphocytes brisk |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Tumour infiltration by lymphocytes non-brisk |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Specimen involvement by macroscopic tumour present |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Specimen involvement by macroscopic tumour absent |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Specimen involvement by macroscopic tumour indeterminate |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Specimen involvement by matted nodes present |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Specimen involvement by matted nodes absent |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Regression of tumour absent |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Regression involving 75 percent or more of tumour, present |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Regression involving less than 75 percent of tumour, present |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Tumour regression finding |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Carcinoma of skin (excluding eyelid, vulva, penis, and melanomas) TNM finding |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
1 |
pT1: Tumour 2 cm or less in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
1 |
pT1a: Tumour 2 cm or less in greatest dimension, limited to dermis or 2 mm or less in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
1 |
pT1b: Tumour 2 cm or less in greatest dimension, limited to dermis and greater than 2 mm in thickness, but not more than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
1 |
pT1c: Tumour 2 cm or less in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
1 |
pT2: Tumour more than 2 cm, but not more than 5 cm, in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
1 |
pT2a: Tumour more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis or greater than 2 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
1 |
pT2b: Tumour more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis and greater than 2 mm in thickness, but not more than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
1 |
pT2c: Tumour more than 2 cm, but not more than 5 cm, in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
1 |
pT3: Tumor more than 5 cm in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
1 |
pT3a: Tumour more than 5 cm in greatest dimension, limited to dermis or not more than 2 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
1 |
pT3b: Tumour more than 5 cm in greatest dimension, limited to dermis and greater than 2 mm in thickness, but not more than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
1 |
pT3c: Tumour more than 5 cm in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
1 |
pT4: Tumour invades deep extradermal structures (i.e. cartilage, skeletal muscle, or bone) (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
1 |
pT4b: Tumour invades deep extradermal structures (i.e. cartilage, skeletal muscle, or bone) greater than 6mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
1 |
pT4a: Tumor invades deep extradermal structures (i.e. cartilage, skeletal muscle, or bone) not more than 6mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
1 |
Stage I: Tumour confined to gland, 5 cm or less (adrenal cortical carcinoma) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Stage II: Tumour confined to gland, greater than 5 cm (adrenal cortical carcinoma) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Stage III: Extraglandular extension of tumour without other organ involvement (adrenal cortical carcinoma) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Stage IV: Distant metastasis or extension into other organs (adrenal cortical carcinoma) |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Raised tumour |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|
Flat tumour |
Associated morphology |
False |
Morphologically abnormal structure |
Inferred relationship |
Some |
|